Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03283137
Brief Title: Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL

First Submitted : September 12, 2017
First Submitted that Met QC Criteria : September 13, 2017
First Posted : September 14, 2017

Last Update Submitted that Met QC Criteria : October 7, 2019
Last Update Posted : October 8, 2019